Article Sidebar
Article Details
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
Main Article Content
Negative effect of non-steroidal anti-inflammatory drugs on the antibacterial activity of ciprofloxacin - an in vitro study
Abstract
Ciprofloxacin, a second generation fluoroquinolone is often co-administered with non-steroidal anti-inflammatory drugs (NSAIDs) in life threatening situations in which Staphylococcus aureus infections are accompanied with pain and inflammation. This study was carried out to investigate possible in vitro interactions in co -administration of ciprofloxacin and some NSAIDs. The study was carried out in the Department of Pharmaceutical Microbiology, Faculty of Pharmacy, and University of Benin, Benin City in 2013. The in vitro evaluation was carried out by incorporating appropriate concentrations of the NSAIDs with ciprofloxacin in 20 ml final volume of Muller Hinton broth in the presence of Staphylococcus aureus and incubated at 37°C in a hot water-bath. Aliquots of 0.1 ml were removed every two hours; serially diluted and plated out on Mannitol Salt agar and incubated at 37oC for 24 hours. The number of colony-forming units (CFU) of Staphylococcus aureus was noted. It was observed that all the NSAIDs reduced the antibacterial activity of ciprofloxacin against Staphylococcus aureus in vitro to varying degrees. The highest reduction was exhibited by acetyl salicylic acid (ASA) as it yielded the highest number of CFU. This was followed closely by piroxicam, then indomethacin and lastly paracetamol (130 cfu; 65 cfu; 43 cfu; and 33 cfu.) respectively. There is a suggestion that the studied NSAIDs and perhaps NSAIDs generally should not be co-administered with ciprofloxacin at the same time.
Keywords: Ciprofloxacin; NSAIDs; Interaction
